Park Medi World net profit surges 35% to ₹886M in Q1FY27
Park Medi World delivered strong Q1FY27 results with net profit rising 35% to ₹886 million and revenue growing 19% to ₹4,757 million. Despite a drop in occupancy to 55.6% due to new capacity additions, EBITDA margins expanded by 20 basis points. The company continues its aggressive expansion strategy with the acquisition of Mehar Hospital in Zirakpur for ₹107 crore.

*this image is generated using AI for illustrative purposes only.
Park Medi World reported a consolidated net profit of ₹886 million for the quarter ended June 30, 2026, marking a 35% year-on-year increase from ₹655 million in Q1FY26. Revenue from operations grew 19% to ₹4,757 million, supported by the commissioning of new facilities and strategic acquisitions. The company also announced the definitive agreement to acquire Mehar Hospital in Zirakpur for ₹107 crore, reinforcing its expansion strategy in North India. This performance underscores the group's ability to scale profitability while executing its largest-ever capacity addition.
The Board of Directors, comprising Chairman Dr. Ajit Gupta and Managing Director Dr. Ankit Gupta, approved the unaudited financial results on August 03, 2026. Statutory auditors Agiwal & Associates issued an unmodified review report on both standalone and consolidated statements. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company maintains a strong balance sheet with negligible term bank debt of ₹256 million as of June 30, 2026, and robust liquidity supported by ₹2,998 million in fixed deposits.
Financial Performance
Q1FY27 highlights demonstrate broad-based growth across key financial metrics, with EBITDA rising 20% to ₹1,261 million and EBITDA margin expanding by 20 basis points to 26.5%. Net profit margin widened significantly by 220 basis points to 18.6%, reflecting operational leverage despite lower occupancy rates at newly commissioned facilities. Earnings per share increased 20% to ₹2.05 from ₹1.70 in the prior year period.
| Particulars: | Q1FY27 (₹ mn) | Q1FY26 (₹ mn) | YoY Growth: |
|---|---|---|---|
| Revenue from Operations: | 4,757 | 3,988 | 19% |
| EBITDA: | 1,261 | 1,049 | 20% |
| EBITDA Margin: | 26.5% | 26.3% | 20 bps |
| Net Profit: | 886 | 655 | 35% |
| Net Profit Margin: | 18.6% | 16.4% | 220 bps |
| EPS (₹): | 2.05 | 1.70 | 20% |
Operational metrics show a 32% increase in total bed capacity to 3,960 beds from 3,000 beds in Q1FY26. However, overall occupancy declined by 1,224 basis points to 55.6% from 67.8%, primarily due to the ramp-up phase of newly commissioned beds. Total patients treated rose 17% to 249,800, with inpatient department (IPD) patients increasing 16% to 26,300 and outpatient department (OPD) patients rising 17% to 223,400.
Strategic Acquisitions and Expansion
Park Medi World continues its aggressive expansion through acquisitions and greenfield projects. On August 03, 2026, the company signed a definitive agreement to acquire Mehar Hospital in Zirakpur for ₹107 crore. The 150+ bed multi-super speciality facility is expected to be commissioned under the Park brand by November 2026, strengthening the group's presence in the Tricity cluster.
This follows the recent commissioning of The Medicity Hospital in Rudrapur, acquired for ₹177 crore, which began operations on August 02, 2026. Additionally, the 350-bed greenfield hospital in Panchkula was commissioned on April 10, 2026. Together with the Agra facility commissioned in February 2026 and the upcoming Febris hospital in Narela, Delhi, the company expects to add 1,490 beds in calendar year 2026. This represents a 46% capacity increase over the 3,250 beds closed in 2025, marking the single largest capacity addition in any 12-month period in the company's history.
What the Numbers Show
The divergence between revenue growth and occupancy decline highlights the transitional nature of Park Medi World's current expansion cycle. While revenue surged 19%, occupancy dropped significantly as new beds came online but had not yet reached stabilization levels. Management noted that the Palam Vihar facility in Gurugram, one of the flagship hospitals, maintained an occupancy of approximately 86% in FY26, delivering ₹245 crore in revenue. The upcoming addition of 100 beds at this location under the 'Park Platinum' brand is expected to further consolidate Gurugram's capacity to 750 beds by November 2026. The company's ability to maintain margin expansion despite lower utilization suggests effective cost management during the integration phase of acquired assets.
Historical Stock Returns for Park Medi World
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.27% | +6.80% | 0.0% | +98.65% | +102.30% | +102.30% |
How long does management estimate it will take for the newly commissioned facilities to reach stabilization occupancy levels and contribute fully to EBITDA margins?
What is the projected impact of the ₹107 crore Mehar Hospital acquisition on Park Medi World's debt-to-equity ratio and overall liquidity position post-integration?
Given the significant drop in overall occupancy to 55.6%, what specific marketing or operational strategies are being deployed to accelerate patient inflow in the Tricity and Rudrapur clusters?


































